Testing effectiveness (Phase 2)UnknownNCT03732495
What this trial is testing
Study of the Efficacy of Lenvatinib Combined With Denosumab in the Treatment of Patients With Predominant Bone Metastatic Radioiodine Refractory Differentiated Thyroid Carcinomas
Who this might be right for
Thyroid Cancer Metastatic
Centre Leon Berard 35